Quetiapine/risperidoneHypothermia and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2040卷 / 1期

关键词：

D O I：

10.1007/s40278-025-73852-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：858 / 858

相关论文

共 50 条

[31] AntineoplasticsFatigue and lack of efficacy: case report
Reactions Weekly, 2023, 1984 (1) : 66 - 66
[32] OctreotideAsystole and lack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 512 - 512
[33] VismodegibFatigue and lack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 461 - 461
[34] PlasmaHypernatraemia and lack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 432 - 432
[35] AntineoplasticsMyelosuppression and lack of efficacy: case report
Reactions Weekly, 2021, 1849 (1) : 51 - 51
[36] AntineoplasticsPseudocirrhosis and lack of efficacy: case report
Reactions Weekly, 2021, 1885 (1) : 75 - 75
[37] DurvalumabColitis and lack of efficacy: case report
Reactions Weekly, 2025, 2056 (1) : 181 - 181
[38] AntineoplasticsNeutropenia and lack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 89 - 89
[39] DurvalumabPneumonitis and lack of efficacy: case report
Reactions Weekly, 2023, 1985 (1) : 208 - 208
[40] AntineoplasticsMyelosuppression and lack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 66 - 66

← 1 2 3 4 5 →